Drug transfer to the fetus and to the breastfeeding infant: What do we know?

Current Drug Delivery

Volumn 9, Issue 4, 2012, Pages 350-355

  Bernick, Steven J ^a   Kane, Sunanda ^b  

^a Naval Hospital Bremerton   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Breastfeeding; Crohn's disease; Fetus; Inflammatory bowel disease; Post partum; Pregnancy; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; FENTANYL; FISH OIL; IMMUNOMODULATING AGENT; INFLIXIMAB; LAXATIVE; METHOTREXATE; METRONIDAZOLE; PETHIDINE; PROPOFOL; THALIDOMIDE;

ARTICLE; BREAST FEEDING; CROHN DISEASE; DRUG ABSORPTION; ENDOSCOPY; ENTERITIS; HUMAN; ILEITIS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL;

EID: 84863555162     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112801323116     Document Type: Article

References (28)

1. FDA. Regulations. 1980, 44, 37434-37467.
2. Mahadevan, U.; Kane, S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology, 2006, 131, 283-311.
3. Qureshi, W.A.; Rajan, E.; Adler, D.G.; Davila, R.E.; Hirota, W.K.; Jacobson, B.C.; Leighton, J.A.; Zuckerman, M.J.; Hambrick, R.D.; Fanelli, R.D.; Baron, T.; Faigel, D.O. ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest. Endosc., 2005, 61, 357.
4. Fairlie, F.M.; Marshall, L.; Walker, J.J.; Elbourne, D. Intramuscular opioids for maternal pain relief in labour: a randomized controlled trial comparing pethidine with diamorphine. Br. J. Obstet. Gynaeco., 1999, 106, 1181-1187.
5. Quinn, P.G.; Kuhneert, B.R.; Kaine, C.J.; Syracuse, C.D. Measurements of meperidine and normeperidine in human breast milk by selected ion monitoring. Biomed. Environ. Mass Spectrom., 1986, 12, 133-135.
6. Briggs, G.G.; Freeman, R.K.; Yaffe, S.J. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 2005.
7. Mahadevan, U. Continuing immunomodulators and biologic medications in pregnant IBD patients-pro. Inflamm. Bowel. Dis., 2007, 13, 1439-1440.
8. Dubinsky, M.; Abraham, B.; Mahadevan, U. Management of the Pregnant IBD Patient. Inflamm. Bowel. Dis., 2008, 14, 1736-1750.
9. Esbjorner, E.; Jamerot, G.; Wranne, L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr. Scand., 1987, 76, 137-142.
10. Subhani, J.M.; Hamilton, M.I. Review article: the management of inflammatory bowel disease during pregnancy. Alim. Pharmacol. Ther., 1998, 12, 1039-1053.
11. Berkovitch, M.; Diav-Citrin, O.; Greenberg, R.; Cohen, M.; Bulkowstein, M.; Shechtman, S.; Bortnik, O.; Arnon, J.; Ornoy, A. First-trimester exposure to amoxicillin/clavulanic acid: a prospective, controlled study. Br. J. Clin. Pharmacol., 2004, 58, 298-302.
12. Beaulieu, D.B.; Ananthakrishnan, A.N.; Issa, M.; Rosenbaum, L.; Skaros, S.; Newcomer, J.R.; Kuhlmann, R.S.; Otterson, M.F.; Emmons, J.; Knox, J.; Binion, D.G. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm. Bowel. Dis., 2009, 15, 25-28.
13. Polifka, J.E.; Friedman, J.M. Teratogen update: azathioprine and 6- mercaptopurine. Teratology, 2002, 65, 240-261.
14. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics, 2001, 108, 776-789.
15. Nguyen, G.; Harris, M.; Dassopoulos, T. Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease. Curr. Gastroenterol. Reports, 2006, 8, 499-505.
16. Christopher, V.; Al-Chalabi, T.; Richsardson, P.D.; et al. Pregnancy outcome after liver transplantation: a single-center experience. Transplant Proc., 2006, 38, 2001-2002.
17. Baumgart, D.C.; Sturm, A.; Wiedenmann, B.; Dignass, A.U. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut, 2005, 54, 1822-1823.
18. Habal, F.; Ravindran, N. Management of inflammatory bowel disease in the pregnant patient. World J. Gastroenterol., 2008, 14, 1326-1332.
19. Kane, S.; Acquah, L. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am. J. Gastroenterol., 2009, 104, 228-233.
20. Katz, J.; Antoni, C.; Keenan, G.; et al. Outcome or pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol., 2004, 99, 2385-2392.
21. Lichtenstein, G.R.; Feagan, B.G.; Cohen, R.D.; Salzberg, B.A.; Diamond, R.H.; Chen, D.M.; Pritchard, M.L.; Sandborn, W.J. Serious infections and mortality in association with therapies for Crohn's disease. TREAT registry. Clin. Gastroenterol. Hepatol., 2006, 4, 621-630.
22. Mahadevan, U.; Abreu, M. Certolizumab use in pregnancy: low levels in cord blood [Abstract program number #960]. Presented at Digestive Diseases Week, June 3, 2009, Chicago, Illinois.
23. ® (natalizumab), Elan Pharmaceuticals, San Francisco Package insert 2007.
24. Wehner, N.; Shopp, G.; Rocca, M.; Clarke, J. Effects of natalizumab, an alpha4 integrin inhibitor, on the development of Hartley guinea pigs. Birth Defects Res. B Dev. Reprod. Toxical., 2009, 82, 98-107.
25. Bozic, C.; Belcher, G.; Kooijmans, M.; Kim, R.; Lynn, F.; Panzara, M.A. The safety of natalizumab in patients with relapsing multiple sclerosis: An update from TOUCH and TYGRIS. Neurology, 2007, 68(Suppl 3) [Abstract].
26. Patlas, N.; Golomb, G.; Yaffe, P.; Pinto, T.; Breuer, E.; Ornoy, A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology, 1999, 60, 68-73.
27. Ornoy, A.; Wajnber, R.; Diav-Citrin, O. The outcome of pregnancy following pre-pregnancy or early pregnancy aledronate treatment. Reprod. Toxicol., 2006, 22, 578-579.
28. Olsen, S.F.; Sorensen, J.D.; Secher, N.J.; Hedegaard, M.; Henriksen, T.B.; Hansen, H.S.; Grant, A. A randomized controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet, 1992, 339, 1003-1007.